PHARMA NEWS

Get the latest NEWS of Pharma World

bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies
Pharma News
By admin / August 27, 2018

bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies

bluebird bio, Inc. (Nasdaq: BLUE)...

Read More
Nippon Kayaku launches Trastuzumab BS for I.V. Infusion 60mg “NK”・150mg “NK”, a humanized anti-human HER2 monoclonal Antibody
Pharma News
By admin / August 27, 2018

Nippon Kayaku launches Trastuzumab BS for I.V. Infusion 60mg “NK”・150mg “NK”, a humanized anti-human HER2 monoclonal Antibody

Nippon Kayaku Co., Ltd. (Head...

Read More
Ubiquigent Launches Drug Discovery Service to Rapidly Identify False Positives
Pharma News
By admin / August 27, 2018

Ubiquigent Launches Drug Discovery Service to Rapidly Identify False Positives

Ubiquigent Limited, a company specialising...

Read More
FDA approves cobas EGFR Mutation Test for use with Iressa in lung cancer
Pharma News
By admin / August 25, 2018

FDA approves cobas EGFR Mutation Test for use with Iressa in lung cancer

The FDA expanded the approval...

Read More
FDA approves Kala Pharma’s eye pain drug
Pharma News
By admin / August 25, 2018

FDA approves Kala Pharma’s eye pain drug

The U.S. Food and Drug...

Read More
Trade margins on medical devices including stents, knee implants set to be capped at 65% in India
Pharma News
By admin / August 25, 2018

Trade margins on medical devices including stents, knee implants set to be capped at 65% in India

India is set to cap...

Read More
AstraZeneca provides update on AERISTO Phase IIIb trial for Bevespi Aerosphere for COPD.
Pharma News
By admin / August 25, 2018

AstraZeneca provides update on AERISTO Phase IIIb trial for Bevespi Aerosphere for COPD.

AstraZeneca announced top-line results from...

Read More
Pfizer and Astellas Amend Protocols for Prostate Cancer Clinical Trials
Pharma News
By admin / August 24, 2018

Pfizer and Astellas Amend Protocols for Prostate Cancer Clinical Trials

Pfizer and Astellas Pharma announced they have...

Read More
FDA approves first drug for neurotrophic keratitis, a rare eye disease
Pharma News
By admin / August 24, 2018

FDA approves first drug for neurotrophic keratitis, a rare eye disease

The U.S. Food and Drug...

Read More
Eisai and Merck Announce European Commission Grants Marketing Authorization for LENVIMA® (lenvatinib) as First-Line Treatment in Adults with Advanced or Unresectable Hepatocellular Carcinoma
Pharma News
By admin / August 24, 2018

Eisai and Merck Announce European Commission Grants Marketing Authorization for LENVIMA® (lenvatinib) as First-Line Treatment in Adults with Advanced or Unresectable Hepatocellular Carcinoma

Eisai and Merck (NYSE: MRK),...

Read More
1 … 108 109 110 111 112 … 154
Offers